Market Cap (In USD)
48.21 Million
Revenue (In USD)
17.06 Thousand
Net Income (In USD)
-8.37 Million
Avg. Volume
-
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.08-0.119
- PE
- -
- EPS
- -
- Beta Value
- 4.679
- ISIN
- US14159C1119
- CUSIP
- 14159C111
- CIK
- 1870144
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Dr. Meeshanthini V. Dogan Ph.D.
- Employee Count
- -
- Website
- https://cardiodiagnosticsinc.com
- Ipo Date
- Details
- Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
More Stocks
-
0LC6Sysco Corporation
0LC6
-
SHREDIGCEMShree Digvijay Cement Company Limited
SHREDIGCEM
-
SUPERTEXSupertex Industries Limited
SUPERTEX
-
MKEXIMM.K. Exim (India) Limited
MKEXIM
-
OLMA
-
GCTKGlucoTrack, Inc.
GCTK
-
VIPCLOTHNGVIP Clothing Limited
VIPCLOTHNG
-
ZUARIINDZuari Industries Limited
ZUARIIND